Table 1 Background data at T1 for patients (N = 36). All figures represent number of patients unless stated
T1 | T2 | T3 | T4 | |
|---|---|---|---|---|
Male | 19 (53%) | |||
Female | 17 (47%) | |||
Mean age (SD) | 60 (10%) | |||
Married/cohabiting | 25 (70%) | |||
Working | 7 (19%) | |||
On sick leave | 14 (39%) | |||
Old age pensioner | 15 (42%) | |||
Metastatic | 25(70%) | 28 (78%) | 28 (78%) | 28 (78%) |
Levels of Chromogranin A, nmol/liter (ref < 4) | 37 | 42 | 53 | 76 |
Levels of U-5HIAA, μmol/h (ref < 2.1) | 13 | 12 | 23 | 14 |
Mean time since surgery, months1,2 (SD) | 3.1 (2.5) | |||
Interferon | 5 (14%) | 8 (22%) | 6 (27%) | 4 (11%) |
Octreotid | 5 (14%) | 6 (27%) | 6 (27%) | 6 (27%) |
Interferon and Octreotid | 6 (27%) | 10 (28%) | 12 (33%) | 9 (25%) |
Other (Chemotherapy) | 4 (11%) | 5 (14%) | 6 (27%) | 3 (<1%) |
Octreotid and chemotherapy | - | - | - | 1 (<1%) |
No treatment | 16 (44%) | 7 (19%) | 6 (27%) | 13 (36%) |